US equities |
NVDA $238.47 ▲+1.93% SPCX $167.02 ▲+5.07% MU $1,063.45 ▼-1.06% TSLA $380.33 ▲+2.63% MSFT $525.41 ▲+1.52% SNDK $1,709.02 ▼-0.64% INTC $117.22 ▼-1.77% META $742.74 ▲+2.01%
FinancialContent

Noveris Health Sciences (OP:MYCOF)

0.7300 UNCHANGED
Last Price Updated: 12:48 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Noveris Health Sciences

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Second-Chance Buying Opportunity With Psychedelic Stock Warrants ↗
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive. 
Via Talk Markets
With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted
Via FinancialNewsMedia
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021 ↗
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
How This Psychedelic Company Could Lead A Turnaround For The Sector ↗
Compass Pathways PLC (NASDAQ:CMPS) is often viewed as the leader in the psychedeli... 
Via Benzinga
Mydecine Unveils Four Psychedelic Drug Candidates ↗
Mydecine Innovations Group (OTC:MYCOF), a Denver-based psychedelics research company... 
Via Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week ↗
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Biotech Companies Driving Psychedelics Industry Forward with Key Research
Via FinancialNewsMedia
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee ↗
Entheon Biomedical Corp. announced the 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >